{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:55:25Z","timestamp":1789631725278,"version":"build-2803163510"},"reference-count":195,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Epstein\u2013Barr virus (EBV) is a ubiquitous oncovirus associated with specific epithelial and lymphoid cancers. Among the epithelial cancers, nasopharyngeal carcinoma (NPC), lymphoepithelioma-like carcinoma (LELC), and EBV-associated gastric cancers (EBVaGC) are the most common. The role of EBV in the pathogenesis of NPC and in the modulation of its tumour immune microenvironment (TIME) has been increasingly well described. Much less is known about the pathogenesis and tumour\u2013microenvironment interactions in other EBV-associated epithelial cancers. Despite the expression of EBV-related viral oncoproteins and a generally immune-inflamed cancer subtype, EBV-associated epithelial cancers have limited systemic therapeutic options beyond conventional chemotherapy. Immune checkpoint inhibitors are effective only in a minority of these patients and even less efficacious with molecular targeting drugs. Here, we examine the key similarities and differences of NPC, LELC, and EBVaGC and comprehensively describe the clinical, pathological, and molecular characteristics of these cancers. A deeper comparative understanding of these EBV-driven cancers can potentially uncover targets in the tumour, TIME, and stroma, which may guide future drug development and cast light on resistance to immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2021.734293","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T05:51:25Z","timestamp":1639115485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Epstein\u2013Barr Virus Epithelial Cancers\u2014A Comprehensive Understanding to Drive Novel Therapies"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuting","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua K.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine Jia Ling","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel Jun Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Poh Sheng","family":"Yeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chwee Ming","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Chong","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1252786","article-title":"Virology. Epstein-Barr Virus Turns 50","volume":"343","author":"Lieberman","year":"2014","journal-title":"Science (New York NY)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The Enigmatic Epidemiology of Nasopharyngeal Carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B3","article-title":"Pathology and Genetics of Head and Neck Tumours (3rd Ed)","volume":"9","author":"Barnes","year":"2005","journal-title":"WHO Classif Tumours"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32774","article-title":"A Comparison of EBV Serology and Serum Cell-Free DNA as Screening Tools for Nasopharyngeal Cancer: Results of the Singapore NPC Screening Cohort","volume":"146","author":"Tay","year":"2020","journal-title":"Int J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-015-0068-9","article-title":"Carcinogenesis of Nasopharyngeal Carcinoma: An Alternate Hypothetical Mechanism","volume":"35","author":"Poh","year":"2016","journal-title":"Chin J Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijc.2910050302","article-title":"On the Epidemiology of Nasopharyngeal Carcinoma","volume":"5","author":"Clifford","year":"1970","journal-title":"Int J Cancer"},{"key":"B7","first-page":"xvii + 610","volume-title":"Scientific Publications No. 20. Nasopharyngeal Carcinoma: Etiology and Control","author":"De-the","year":"1978"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801101)46:9<2100::aid-cncr2820460932>3.0.co;2-g","article-title":"Nasopharyngeal Carcinoma in Alaskan Eskimos Indians, and Aleuts: A Review of Cases and Study of Epstein-Barr Virus, HLA, and Environmental Risk Factors","volume":"46","author":"Lanier","year":"1980","journal-title":"Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009416","article-title":"Lymphoepithelioma-Like Hepatocellular Carcinoma: A Case Report and Brief Review of Literature","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05775.x","article-title":"Clinicopathological and Molecular Characteristics of Epstein\u2013Barr Virus-Associated Gastric Carcinoma: A Meta-Analysis","volume":"24","author":"Lee","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ctrv.2018.03.006","article-title":"Outlooks on Epstein-Barr Virus Associated Gastric Cancer","volume":"66","author":"Naseem","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs320","article-title":"An Epidemiological and Molecular Study of the Relationship Between Smoking, Risk of Nasopharyngeal Carcinoma, and Epstein-Barr Virus Activation","volume":"104","author":"Xu","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-1175","article-title":"Independent Effect of EBV and Cigarette Smoking on Nasopharyngeal Carcinoma: A 20-Year Follow-Up Study on 9,622 Males Without Family History in Taiwan","volume":"18","author":"Hsu","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Re Cosponsored Am Soc Prev Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.149","article-title":"Epstein-Barr Virus as a Paradigm in Nasopharyngeal Cancer: From Lab to Clinic","author":"Raghupathy","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199509143331103","article-title":"Clonal Proliferations of Cells Infected With Epstein\u2013Barr Virus in Preinvasive Lesions Related to Nasopharyngeal Carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603609","article-title":"Sustained Elevation of Epstein-Barr Virus Antibody Levels Preceding Clinical Onset of Nasopharyngeal Carcinoma","volume":"96","author":"Ji","year":"2007","journal-title":"Br J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602347","article-title":"Further Evidence for an HLA-Related Recessive Mutation in Nasopharyngeal Carcinoma Among the Chinese","volume":"92","author":"Hu","year":"2005","journal-title":"Br J Cancer"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.054","article-title":"The Epidemiology of EBV and its Association With Malignant Disease","volume-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Hjalgrim","year":"2007"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930360413","article-title":"Epstein-Barr Virus Related Lymphoepithelioma-Like Carcinoma of Lung","volume":"36","author":"B\u00e9gin","year":"1987","journal-title":"J Surg Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.08.40","article-title":"Clinicopathological Features and Prognosis of Primary Pulmonary Lymphoepithelioma-Like Carcinoma","volume":"8","author":"Jiang","year":"2016","journal-title":"J Thorac Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.2856","article-title":"Update on Epstein-Barr Virus and Gastric Cancer (Review)","volume":"46","author":"Shinozaki-Ushiku","year":"2015","journal-title":"Int J Oncol"},{"key":"B22","article-title":"Environmental Factors Related to Gastric Cancer Associated With Epstein-Barr Virus in Colombia","volume":"7","author":"Campos","year":"2005","journal-title":"Asian Pac J Cancer Prev: APJCP"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10197","article-title":"Epstein-Barr Virus and Nasopharyngeal Carcinoma","volume":"33","author":"Young","year":"2014","journal-title":"Chin J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197909)44:3<1029::aid-cncr2820440335>3.0.co;2-5","article-title":"Histopathology of Nasopharyngeal Carcinoma: Correlations With Epidemiology, Survival Rates and Other Biological Characteristics","volume":"44","author":"Shanmugaratnam","year":"1979","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640207","article-title":"The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy","volume":"11","author":"Lo","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.323","article-title":"Pulmonary Lymphoepithelioma-Like Carcinoma: Predominant Infiltration of Tumor-Associated Cytotoxic T Lymphocytes Might Represent the Enhanced Tumor Immunity","volume":"43","author":"Kobayashi","year":"2004","journal-title":"Internal Med (Tokyo Jpn)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001173","article-title":"Epstein-Barr Virus-Associated Pulmonary Carcinoma: Proposing an Alternative Term and Expanding the Histologic Spectrum of Lymphoepithelioma-Like Carcinoma of the Lung","volume":"43","author":"Yeh","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2651716","DOI":"10.1155\/2018\/2651716","article-title":"Very Rare Liver Neoplasm: Lymphoepithelioma-Like (LEL) Hepatocellular Carcinoma","volume":"2018","author":"Filotico","year":"2018","journal-title":"Case Rep Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.02.022","article-title":"Lymphoepithelioma-Like Carcinoma in Liver","volume":"187","author":"Labgaa","year":"2017","journal-title":"Am J Pathol"},{"key":"B30","article-title":"Primary Lymphoepithelioma-Like Carcinoma of Salivary Glands: A Clinicopathological Study of 21 Cases","volume":"7","author":"Zhao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/ajm.AJM_135_17","article-title":"CD4-Positive Lymphoepithelial-Like Carcinoma: Report of Unusual Case","volume":"8","author":"Aziz","year":"2018","journal-title":"Avicenna J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11949","article-title":"Programmed Death-Ligand 1 is Upregulated in Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B33","article-title":"Soft and Hard Keratin Expression in Epstein-Barr-Virus-Associated Gastric Carcinoma","volume":"25","author":"Uozaki","year":"2005","journal-title":"Anticancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-22822-8_8","article-title":"EBV Persistence\u2013Introducing the Virus","volume":"390","author":"Thorley-Lawson","year":"2015","journal-title":"Curr Topics Microbiol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal Differentiation Into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.4.567","article-title":"Epstein-Barr Virus-Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients","volume":"190","author":"Babcock","year":"1999","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80493-8","article-title":"Is EBV Persistence In Vivo a Model for B Cell Homeostasis","volume":"5","author":"Khan","year":"1996","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0092-8674(95)90513-8","article-title":"A Novel Form of Epstein-Barr Virus Latency in Normal B Cells In Vivo","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin Receptor A2 is an Epithelial Cell Receptor for Epstein-Barr Virus Entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/path.4448","article-title":"The Role of Epstein-Barr Virus in Epithelial Malignancies","volume":"235","author":"Tsao","year":"2015","journal-title":"J Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-Canonical NF-kappaB Signaling Pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-70630-6_14","article-title":"LMP1 TRAFficking Activates Growth and Survival Pathways","volume":"597","author":"Soni","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M505903200","article-title":"The C-Terminal Activating Region 2 of the Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Activates NF-kappaB Through TRAF6 and TAK1","volume":"281","author":"Wu","year":"2006","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2237183100","article-title":"Epstein-Barr Virus Latent Infection Membrane Protein 1 TRAF-Binding Site Induces NIK\/IKK Alpha-Dependent Noncanonical NF-kappaB Activation","volume":"101","author":"Luftig","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-011-0019-3","article-title":"Association of Fluoropyrimidines, Platinum Agents, Taxanes, and Irinotecan in Any Line of Chemotherapy With Survival in Patients With Advanced Gastric Cancer","volume":"14","author":"Shitara","year":"2011","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2217\/fon.09.53","article-title":"Role of the Epstein-Barr Virus-Encoded Latent Membrane Protein-1, LMP1, in the Pathogenesis of Nasopharyngeal Carcinoma","volume":"5","author":"Morris","year":"2009","journal-title":"Future Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.32","article-title":"Targeting Epstein-Barr Virus Oncoprotein LMP1-Mediated Glycolysis Sensitizes Nasopharyngeal Carcinoma to Radiation Therapy","volume":"33","author":"Xiao","year":"2014","journal-title":"Oncogene"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02168-16","article-title":"Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the Mtorc1\/NF-\u03bab Signaling Pathways","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i19.5694","article-title":"Role of microRNAs in Gastric Cancer","volume":"20","author":"Ishiguro","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80623-8","article-title":"Epstein-Barr Virus LMP2A Drives B Cell Development and Survival in the Absence of Normal B Cell Receptor Signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr Virus Provides a Survival Factor to Burkitt\u2019s Lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2011.12.001","article-title":"The Role of miRNAs and EBV BARTs in NPC","volume":"22","author":"Marquitz","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00613-16","article-title":"NF-\u03bab Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma","volume":"90","author":"Verhoeven","year":"2016","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijc.28007","article-title":"Targeting of DICE1 Tumor Suppressor by Epstein\u2013Barr Virus-Encoded miR-BART3* microRNA in Nasopharyngeal Carcinoma. Https:\/\/Doi.Org\/10.1002\/Ijc.28007","volume":"133","author":"Lei","year":"2013","journal-title":"Int J Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8353","article-title":"Epstein-Barr Virus-Encoded microRNA BART1 Induces Tumour Metastasis by Regulating PTEN-Dependent Pathways in Nasopharyngeal Carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01120","article-title":"Epstein-Barr Virus BART Long Non-Coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma. Original Research","volume":"9","author":"Verhoeven","year":"2019","journal-title":"Front Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071940","article-title":"The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies","volume":"12","author":"Lo","year":"2020","journal-title":"Cancers"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10689","article-title":"Frequent Chromosome 9p Losses in Histologically Normal Nasopharyngeal Epithelia From Southern Chinese. Https:\/\/Doi.Org\/10.1002\/Ijc.10689","volume":"102","author":"Chan","year":"2002","journal-title":"Int J Cancer"},{"key":"B59","article-title":"High Frequency of Chromosome 3p Deletion in Histologically Normal Nasopharyngeal Epithelia From Southern Chinese","volume":"60","author":"Chan","year":"2000","journal-title":"Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2016.03.06","article-title":"Genetic and Epigenetic Landscape of Nasopharyngeal Carcinoma","volume":"5","author":"Dai","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"B61","article-title":"P16 Gene Alterations in Nasopharyngeal Carcinoma","volume":"55","author":"Lo","year":"1995","journal-title":"Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202637109","article-title":"Cyclin D1 Overexpression Supports Stable EBV Infection in Nasopharyngeal Epithelial Cells","volume":"109","author":"Tsang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690818","article-title":"Inhibiting Tumorigenic Potential by Restoration of P16 in Nasopharyngeal Carcinoma","volume":"81","author":"Wang","year":"1999","journal-title":"Br J Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10902-w","article-title":"The Genomic Landscape of Epstein-Barr Virus-Associated Pulmonary Lymphoepithelioma-Like Carcinoma","volume":"10","author":"Hong","year":"2019","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00382-6","article-title":"Molecular Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma Based on Integrated Genomic Analyses","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/cancers12082065","article-title":"Distinct Molecular Landscape of Epstein-Barr Virus Associated Pulmonary Lymphoepithelioma-Like Carcinoma Revealed by Genomic Sequencing","volume":"12","author":"Chau","year":"2020","journal-title":"Cancers"},{"key":"B67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5501\/wjv.v1.i1.31","article-title":"Serological Diagnosis of Epstein-Barr Virus Infection: Problems and Solutions","volume":"1","author":"De Paschale","year":"2012","journal-title":"World J Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2174\/1568009616666160926124923","article-title":"Epstein-Barr Virus-Associated Gastric Cancer and Potential Mechanisms of Oncogenesis","volume":"17","author":"Morales-Sanchez","year":"2017","journal-title":"Curr Cancer Drug Targets"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.412","article-title":"Transcriptional Analysis of Epstein-Barr Virus Gene Expression in EBV-Positive Gastric Carcinoma: Unique Viral Latency in the Tumour Cells","volume":"74","author":"Sugiura","year":"1996","journal-title":"Br J Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i5.629","article-title":"Expression of Epstein-Barr Virus Genes in EBV-Associated Gastric Carcinomas","volume":"11","author":"Luo","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-7-21","article-title":"Epstein-Barr Virus Infected Gastric Adenocarcinoma Expresses Latent and Lytic Viral Transcripts and has a Distinct Human Gene Expression Profile","volume":"7","author":"Tang","year":"2012","journal-title":"Infect Agents Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4620","article-title":"Downregulation of microRNA-200 in EBV-Associated Gastric Carcinoma","volume":"70","author":"Shinozaki","year":"2010","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3006","article-title":"The Genomic Landscape of Nasopharyngeal Carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nat Genet"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14121","article-title":"Exome and Genome Sequencing of Nasopharynx Cancer Identifies NF-\u03bab Pathway Activating Mutations","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/thno.29622","article-title":"Genome-Wide Profiling of Epstein-Barr Virus Integration by Targeted Sequencing in Epstein-Barr Virus Associated Malignancies","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1038\/s41467-021-24348-6","article-title":"Whole-Genome Profiling of Nasopharyngeal Carcinoma Reveals Viral-Host Co-Operation in Inflammatory NF-\u03bab Activation and Immune Escape","volume":"12","author":"Bruce","year":"2021","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i12.3472","article-title":"Lessons From Rare Tumors: Hepatic Lymphoepithelioma-Like Carcinomas","volume":"21","author":"Solinas","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26410","article-title":"Rediscovery of NF-\u03bab Signaling in Nasopharyngeal Carcinoma: How Genetic Defects of NF-\u03bab Pathway Interplay With EBV in Driving Oncogenesis","volume":"233","author":"Yi","year":"2018","journal-title":"J Cell Physiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-Driven LMP1 and IFN-\u03b3 Up-Regulate PD-L1 in Nasopharyngeal Carcinoma: Implications for Oncotargeted Therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10080","article-title":"Epigenetic Disruption of Cell Signaling in Nasopharyngeal Carcinoma","volume":"30","author":"Li","year":"2011","journal-title":"Chin J Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629780","article-title":"The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies","volume":"11","author":"Leong","year":"2021","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2194","article-title":"Activation of DNA Methyltransferase 1 by EBV LMP1 Involves C-Jun NH(2)-Terminal Kinase Signaling","volume":"66","author":"Tsai","year":"2006","journal-title":"Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.152059399","article-title":"The Epstein-Barr Virus Oncogene Product, Latent Membrane Protein 1, Induces the Downregulation of E-Cadherin Gene Expression via Activation of DNA Methyltransferases","volume":"99","author":"Tsai","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3070","article-title":"Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma","volume":"69","author":"Hino","year":"2009","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.virol.2019.06.006","article-title":"LMP2A Induces DNA Methylation and Expression Repression of AQP3 in EBV-Associated Gastric Carcinoma","volume":"534","author":"Wang","year":"2019","journal-title":"Virology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00054","article-title":"H3K27me3 Protein Is a Promising Predictive Biomarker of Patients\u2019 Survival and Chemoradioresistance in Human Nasopharyngeal Carcinoma","volume":"17","author":"Cai","year":"2011","journal-title":"Mol Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.254","article-title":"EZH2 Supports Nasopharyngeal Carcinoma Cell Aggressiveness by Forming a Co-Repressor Complex With HDAC1\/HDAC2 and Snail to Inhibit E-Cadherin","volume":"31","author":"Tong","year":"2012","journal-title":"Oncogene"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.7785\/tcrt.2012.500315","article-title":"EZH2 Regulates the Expression of P16 in the Nasopharyngeal Cancer Cells","volume":"12","author":"Zhong","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0391-9","article-title":"A Multicenter Analysis of Genomic Profiles and PD-L1 Expression of Primary Lymphoepithelioma-Like Carcinoma of the Lung","volume":"33","author":"Xie","year":"2020","journal-title":"Mod Pathol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64901-2","article-title":"Epstein-Barr Virus-Positive Gastric Carcinoma Demonstrates Frequent Aberrant Methylation of Multiple Genes and Constitutes CpG Island Methylator Phenotype-Positive Gastric Carcinoma","volume":"160","author":"Kang","year":"2002","journal-title":"Am J Pathol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.9.669","article-title":"Epstein-Barr Virus in Gastric Adenocarcinomas: Association With Ethnicity and CDKN2A Promoter Methylation","volume":"55","author":"Vo","year":"2002","journal-title":"J Clin Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1349-7006.2003.tb01355.x","article-title":"Global and non-Random CpG-Island Methylation in Gastric Carcinoma Associated With Epstein-Barr Virus","volume":"94","author":"Chong","year":"2003","journal-title":"Cancer Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11701","article-title":"Promoter Hypermethylation ofE-Cadherin and Its Abnormal Expression in Epstein-Barr Virus-Associated Gastric Carcinoma","volume":"109","author":"Sudo","year":"2004","journal-title":"Int J Cancer J Int Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-014-4654-3","article-title":"Hypermethylation of the Interferon Regulatory Factor 5 Promoter in Epstein-Barr Virus-Associated Gastric Carcinoma","volume":"53","author":"Dong","year":"2015","journal-title":"J Microbiol (Seoul Korea)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480","article-title":"Comprehensive Molecular Characterization of Gastric Adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27724","article-title":"Genome-Wide Identification of Epstein-Barr Virus-Driven Promoter Methylation Profiles of Human Genes in Gastric Cancer Cells","volume":"119","author":"Zhao","year":"2013","journal-title":"Cancer"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19423","article-title":"Histone Modification Alteration Coordinated With Acquisition of Promoter DNA Methylation During Epstein-Barr Virus Infection","volume":"8","author":"Funata","year":"2017","journal-title":"Oncotarget"},{"key":"B98","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1038\/s41598-017-08370-7","article-title":"Regulation of Tumour Related Genes by Dynamic Epigenetic Alteration at Enhancer Regions in Gastric Epithelial Cells Infected by Epstein-Barr Virus","volume":"7","author":"Okabe","year":"2017","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(00)70355-6","article-title":"Epstein-Barr Virus-Associated Gastric Carcinomas: Relation to H. Pylori Infection and Genetic Alterations","volume":"118","author":"Wu","year":"2000","journal-title":"Gastroenterology"},{"key":"B100","article-title":"P53 Overexpression is Different in Epstein-Barr Virus-Associated and Epstein-Barr Virus-Negative Carcinoma","volume":"33","author":"Leung","year":"1998","journal-title":"Histopathology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00376.x","article-title":"Infrequent Overexpression of P53 Protein in Epstein-Barr Virus-Associated Gastric Carcinomas","volume":"88","author":"Ojima","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.015081","article-title":"Role of P53, Apoptosis, and Cell Proliferation in Early Stage Epstein-Barr Virus Positive and Negative Gastric Carcinomas","volume":"57","author":"Ishii","year":"2004","journal-title":"J Clin Pathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12885-015-1813-9","article-title":"Prognostic Significance of Epstein-Barr Virus Infection in Gastric Cancer: A Meta-Analysis","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-9211-0_8","article-title":"Mutant P53 and the Response to Chemotherapy and Radiation","volume":"85","author":"Tchelebi","year":"2014","journal-title":"Subcell Biochem"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2018-4750","article-title":"Abstract 4750: The Immunosuppressive Tumor Microenvironment (TME) in Nasopharyngeal Carcinoma: Implications for Immunotherapy","volume":"78","author":"Duffield","year":"2018","journal-title":"Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","article-title":"Comprehensive Single-Cell Sequencing Reveals the Stromal Dynamics and Tumor-Specific Characteristics in the Microenvironment of Nasopharyngeal Carcinoma","volume":"12","author":"Gong","year":"2021","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e1122","DOI":"10.1371\/journal.pone.0001122","article-title":"Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy","volume":"2","author":"Li","year":"2007","journal-title":"PLoS One"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0134","article-title":"Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1073\/pnas.1701836114","article-title":"Mouse Model of Epstein\u2013Barr Virus LMP1- and LMP2A-Driven Germinal Center B-Cell Lymphoproliferative Disease","volume":"114","author":"Minamitani","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/path.1745","article-title":"Expression of the Interferon-Inducible Chemokine IP-10 (CXCL10), A Chemokine With Proposed Anti-Neoplastic Functions, in Hodgkin Lymphoma and Nasopharyngeal Carcinoma","volume":"206","author":"Teichmann","year":"2005","journal-title":"J Pathol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.06.037","article-title":"Endogenous Latent Membrane Protein 1 in Epstein-Barr Virus-Infected Nasopharyngeal Carcinoma Cells Attracts T Lymphocytes Through Upregulation of Multiple Chemokines","volume":"405","author":"Lai","year":"2010","journal-title":"Virology"},{"key":"B112","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.69.5.779","article-title":"Interleukin-18 Expression Induced by Epstein-Barr Virus-Infected Cells","volume":"69","author":"Yao","year":"2001","journal-title":"J Leukoc Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S179367","article-title":"Interleukin-18 Promoter Genotype Is Associated With the Risk of Nasopharyngeal Carcinoma in Taiwan","volume":"10","author":"Huang","year":"2018","journal-title":"Cancer Manage Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203521","article-title":"Key Genes Affecting the Progression of Nasopharyngeal Carcinoma Identified by RNA-Sequencing and Bioinformatic Analysis","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/617143","article-title":"Expression and Prognostic Significance of Macrophage Inflammatory Protein-3 Alpha and Cystatin A in Nasopharyngeal Carcinoma","volume":"2015","author":"Tang","year":"2015","journal-title":"BioMed Res Int"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1097\/MD.0000000000000123","article-title":"Increased Serum Levels of Macrophage Inflammatory Protein-3\u03b1 and Cystatin a Predict a Poor Prognosis of Nasopharyngeal Carcinoma","volume":"93","author":"Cai","year":"2014","journal-title":"Med (Baltimore)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21557","article-title":"Multiplexed Immunobead-Based Profiling of Cytokine Markers for Detection of Nasopharyngeal Carcinoma and Prognosis of Patient Survival","volume":"33","author":"Chang","year":"2011","journal-title":"Head Neck"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0090","article-title":"Macrophage Inflammatory Protein-3alpha Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes","volume":"14","author":"Chang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju363","article-title":"Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells","volume":"107","author":"Mrizak","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 Induces M2-Like Macrophage Polarization via SNAIL-Mediated Suppression of a Pro-Inflammatory Phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001588","article-title":"EBV-EBNA1 Constructs an Immunosuppressive Microenvironment for Nasopharyngeal Carcinoma by Promoting the Chemoattraction of Treg Cells","volume":"8","author":"Huo","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3213","article-title":"Mechanisms of Epstein-Barr Virus Nuclear Antigen 1 Favor Tregs Accumulation in Nasopharyngeal Carcinoma","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4552","article-title":"EBV-Encoded RNA via TLR3 Induces Inflammation in Nasopharyngeal Carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.01.015","article-title":"Epstein-Barr Virus Noncoding RNAs From the Extracellular Vesicles of Nasopharyngeal Carcinoma (NPC) Cells Promote Angiogenesis via TLR3\/RIG-I-Mediated VCAM-1 Expression","volume":"1865","author":"Cheng","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B125","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oraloncology.2017.02.002","article-title":"Characterization of PD-L1 Expression and Immune Cell Infiltration in Nasopharyngeal Cancer","volume":"67","author":"Chan","year":"2017","journal-title":"Oral Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000449","article-title":"Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-Infiltrating Lymphocyte in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma","volume":"41","author":"Larbcharoensub","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-4","article-title":"Different Subsets of Tumor Infiltrating Lymphocytes Correlate With NPC Progression in Different Ways","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/path.1236","article-title":"High Numbers of Granzyme B\/CD8-Positive Tumour-Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Biopsies Predict Rapid Fatal Outcome in Patients Treated With Curative Intent","volume":"198","author":"Oudejans","year":"2002","journal-title":"J Pathol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-189","article-title":"Distribution, Characterization, and Induction of CD8+ Regulatory T Cells and IL-17-Producing CD8+ T Cells in Nasopharyngeal Carcinoma","volume":"9","author":"Li","year":"2011","journal-title":"J Trans Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and During Interleukin-2 Therapy","volume":"6","author":"Churlaud","year":"2015","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.130","article-title":"Increase of Programmed Death-1-Expressing Intratumoral CD8 T Cells Predicts a Poor Prognosis for Nasopharyngeal Carcinoma","volume":"23","author":"Hsu","year":"2010","journal-title":"Mod Pathol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12885-019-5689-y","article-title":"PD-1 High Expression Predicts Lower Local Disease Control in Stage IV M0 Nasopharyngeal Carcinoma","volume":"19","author":"Jiang","year":"2019","journal-title":"BMC Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/path.4781","article-title":"Exosomal miR-24-3p Impedes T-Cell Function by Targeting FGF11 and Serves as a Potential Prognostic Biomarker for Nasopharyngeal Carcinoma","volume":"240","author":"Ye","year":"2016","journal-title":"J Pathol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01906","article-title":"Hypoxia Induces Mitochondrial Defect That Promotes T Cell Exhaustion in Tumor Microenvironment Through MYC-Regulated Pathways","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813320106","article-title":"Decreased EBNA-1-Specific CD8+ T Cells in Patients With Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma","volume":"106","author":"Fogg","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.367532","article-title":"Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-Producing Tumor-Infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients","volume":"287","author":"Li","year":"2012","journal-title":"J Biol Chem"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for Early-Differentiated Natural Killer Cells in Infectious Mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0374-x","article-title":"Single-Cell Transcriptomics Reveals Regulators Underlying Immune Cell Diversity and Immune Subtypes Associated With Prognosis in Nasopharyngeal Carcinoma","volume":"30","author":"Chen","year":"2020","journal-title":"Cell Res"},{"key":"B139","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/pathogens7020040","article-title":"The Microenvironment in Epstein-Barr Virus-Associated Malignancies","volume":"7","author":"Tan","year":"2018","journal-title":"Pathog (Basel Switzerland)"},{"key":"B140","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"B141","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1038\/s41586-020-2326-5","article-title":"Author Correction: A Conserved Dendritic-Cell Regulatory Program Limits Antitumour Immunity","volume":"582","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S167071","article-title":"The Prognostic Significance of Carcinoma-Associated Fibroblasts and Tumor-Associated Macrophages in Nasopharyngeal Carcinoma","volume":"10","author":"Yu","year":"2018","journal-title":"Cancer Manage Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e1006503","DOI":"10.1371\/journal.ppat.1006503","article-title":"LMP1-Mediated Glycolysis Induces Myeloid-Derived Suppressor Cell Expansion in Nasopharyngeal Carcinoma","volume":"13","author":"Cai","year":"2017","journal-title":"PLoS Pathog"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.040","article-title":"Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma","volume":"29","author":"Hopkins","year":"2021","journal-title":"Mol Ther"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2012.483","article-title":"Comparative Proteomic Analysis of Secreted Proteins From Nasopharyngeal Carcinoma-Associated Stromal Fibroblasts and Normal Fibroblasts","volume":"3","author":"Ge","year":"2012","journal-title":"Exp Ther Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318249c4b8","article-title":"Epstein-Barr Virus-Associated Gastric Carcinoma: A Newly Defined Entity","volume":"46","author":"Chen","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/pathogens9010008","article-title":"Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, Lmp1","volume":"9","author":"Morris","year":"2019","journal-title":"Pathog (Basel Switzerland)"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01292-5","article-title":"Unraveling Tumour Microenvironment Heterogeneity in Nasopharyngeal Carcinoma Identifies Biologically Distinct Immune Subtypes Predicting Prognosis and Immunotherapy Responses","volume":"20","author":"Chen","year":"2021","journal-title":"Mol Cancer"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21043-4","article-title":"Tumour Heterogeneity and Intercellular Networks of Nasopharyngeal Carcinoma at Single Cell Resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-814936-2.00003-1","volume-title":"Chapter 3 - Pathogenesis of Nasopharyngeal Carcinoma: Histogenesis, Epstein\u2013Barr Virus Infection, and Tumor Microenvironment","author":"Tsang","year":"2019"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10040106","article-title":"Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma","volume":"10","author":"Huang","year":"2018","journal-title":"Cancers"},{"key":"B152","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00262-002-0333-z","article-title":"Interferon-Gamma Secretion and Perforin Expression Are Impaired in CD8+ T Lymphocytes From Patients With Undifferentiated Carcinoma of Nasopharyngeal Type","volume":"52","author":"Zanussi","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001215)88:6<949::AID-IJC18>3.0.CO;2-6","article-title":"Heterogeneity of HLA and EBER Expression in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma","volume":"88","author":"Yao","year":"2000","journal-title":"Int J Cancer"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood Diffusion and Th1-Suppressive Effects of Galectin-9-Containing Exosomes Released by Epstein-Barr Virus-Infected Nasopharyngeal Carcinoma Cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.0388","article-title":"Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)","volume":"36","author":"Ma","year":"2018","journal-title":"J Clin Oncol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s241337","article-title":"Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review","volume":"13","author":"Hu","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(99)80120-4","article-title":"Case Report of Lymphoepithelioma-Like Carcinoma of the Lung\u2013Lymphoid Population Consisting of Cytotoxic T Cells in Resting State","volume":"195","author":"Kasai","year":"1999","journal-title":"Pathol Res Pract"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200206000-00004","article-title":"New Aspects in Clinicopathologic and Oncogene Studies of 23 Pulmonary Lymphoepithelioma-Like Carcinomas","volume":"26","author":"Chang","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"B159","article-title":"Identification of Discriminatory Gene Expression of EBV-Associated Primary Lymphoepithelioma-Like Carcinoma of Lung by Oligonucleotide Microarray Analysis","volume":"65","author":"Wong","year":"2005","journal-title":"Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980615)82:12<2334::aid-cncr6>3.0.co;2-s","article-title":"Epstein-Barr Virus-Associated Nonsmall Cell Lung Carcinoma: Undifferentiated \u201cLymphoepithelioma-Like\u201d Carcinoma as a Distinct Entity With Better Prognosis","volume":"82","author":"Chen","year":"1998","journal-title":"Cancer"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1175","article-title":"Partial Absence of PD-1 Expression by Tumor-Infiltrating EBV-Specific CD8(+) T Cells in EBV-Driven Lymphoepithelioma-Like Carcinoma","volume":"9","author":"Simoni","year":"2020","journal-title":"Clin Trans Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17945","article-title":"Differentiated Tumor Immune Microenvironment of Epstein-Barr Virus-Associated and Negative Gastric Cancer: Implication in Prognosis and Immunotherapy","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5028","article-title":"PD-L1 is Remarkably Over-Expressed in EBV-Associated Pulmonary Lymphoepithelioma-Like Carcinoma and Related to Poor Disease-Free Survival","volume":"6","author":"Fang","year":"2015","journal-title":"Oncotarget"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71775-4","article-title":"High MHC-II Expression in Epstein-Barr Virus-Associated Gastric Cancers Suggests That Tumor Cells Serve an Important Role in Antigen Presentation","volume":"10","author":"Ghasemi","year":"2020","journal-title":"Sci Rep"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.061","article-title":"EBV-Positive Gastric Adenocarcinomas: A Distinct Clinicopathologic Entity With a Low Frequency of Lymph Node Involvement","volume":"22","author":"van Beek","year":"2004","journal-title":"J Clin Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9076","article-title":"Abundant PD-L1 Expression in Epstein-Barr Virus-Infected Gastric Cancers","volume":"7","author":"Derks","year":"2016","journal-title":"Oncotarget"},{"key":"B167","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10120-018-00922-8","article-title":"Predictive Factors for Hyperprogressive Disease During Nivolumab as Anti-PD1 Treatment in Patients With Advanced Gastric Cancer","volume":"22","author":"Sasaki","year":"2019","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"B168","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humpath.2016.06.002","article-title":"Low Density of CD204-Positive M2-Type Tumor-Associated Macrophages in Epstein-Barr Virus-Associated Gastric Cancer: A Clinicopathologic Study With Digital Image Analysis","volume":"56","author":"Ichimura","year":"2016","journal-title":"Hum Pathol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e1356144","DOI":"10.1080\/2162402X.2017.1356144","article-title":"Analysis of PD1, PDL1, PDL2 Expression and T Cells Infiltration in 1014 Gastric Cancer Patients","volume":"7","author":"Xing","year":"2017","journal-title":"Oncoimmunology"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152881","article-title":"High PD-L1 Expression in Gastric Cancer (GC) Patients and Correlation With Molecular Features","volume":"216","author":"Liu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001253","article-title":"Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype","volume":"43","author":"Kim","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.01.019","article-title":"STING Activation Enhances Cetuximab-Mediated NK Cell Activation and DC Maturation and Correlates With HPV(+) Status in Head and Neck Cancer","volume":"78","author":"Lu","year":"2018","journal-title":"Oral Oncol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586752","article-title":"Clinicopathological and Immunomicroenvironment Characteristics of Epstein-Barr Virus-Associated Gastric Cancer in a Chinese Population","volume":"10","author":"Jia","year":"2020","journal-title":"Front Oncol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr Virus microRNAs Reduce Immune Surveillance by Virus-Specific CD8+ T Cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2018.09.002","article-title":"An Integrated Automated Multispectral Imaging Technique That Simultaneously Detects and Quantitates Viral RNA and Immune Cell Protein Markers in Fixed Sections From Epstein-Barr Virus-Related Tumours","volume":"37","author":"Wee","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02688-4","article-title":"Chemotherapy Negatively Impacts the Tumor Immune Microenvironment in NSCLC: An Analysis of Pre- and Post-Treatment Biopsies in the Multi-Center SAKK19\/09 Study","volume":"70","author":"Amrein","year":"2021","journal-title":"Cancer Immunol Immunother: CII"},{"key":"B177","first-page":"1","article-title":"From Bench to Bedside: The Growing Use of Translational Research in Cancer Medicine","volume":"2","author":"Goldblatt","year":"2010","journal-title":"Am J Transl Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.3675","article-title":"Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study","volume":"35","author":"Hsu","year":"2017","journal-title":"J Clin Oncol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20308-8","article-title":"Somatostatin Receptor 2 Expression in Nasopharyngeal Cancer is Induced by Epstein Barr Virus Infection: Impact on Prognosis, Imaging and Therapy","volume":"12","author":"Lechner","year":"2021","journal-title":"Nat Commun"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S290113","article-title":"Pulmonary Lymphoepithelioma-Like Carcinoma Treated With Immunotherapy or Chemotherapy: A Single Institute Experience","volume":"14","author":"Fu","year":"2021","journal-title":"OncoTargets Ther"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)01281-7","article-title":"Pembrolizumab Versus Docetaxel for Previously Treated, PD-L1-Positive, Advanced non-Small-Cell Lung Cancer (KEYNOTE-010): A Randomised Controlled Trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3529","article-title":"Efficacy of PD-1 or PD-L1 Inhibitors and PD-L1 Expression Status in Cancer: Meta-Analysis","volume":"362","author":"Shen","year":"2018","journal-title":"BMJ"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0752-4","article-title":"Development and Validation of an Immune Checkpoint-Based Signature to Predict Prognosis in Nasopharyngeal Carcinoma Using Computational Pathology Analysis","volume":"7","author":"Wang","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B184","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1158\/1078-0432.CCR-20-1727","article-title":"Integration of Antiangiogenic Therapy With Cisplatin and Gemcitabine Chemotherapy in Patients With Nasopharyngeal Carcinoma","volume":"26","author":"Chong","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2016.03.20","article-title":"Therapeutic Vaccination Strategies to Treat Nasopharyngeal Carcinoma","volume":"5","author":"Taylor","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies With Curative Potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.AACRAHNS19-B03","article-title":"Abstract B03: A Phase I Study of Cetuximab Followed by Activated and Expanded NK Cells for Refractory Nasopharyngeal Cancer","volume":"26","author":"Lim","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B188","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/cco.2016.03.08","article-title":"Immunotherapy for Nasopharyngeal Cancer\u2014a Review","volume":"5","author":"Jain","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137139","article-title":"Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review","volume":"136","author":"Farooqi","year":"2020","journal-title":"Blood"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.242","article-title":"Adoptive T-Cell Transfer and Chemotherapy in the First-Line Treatment of Metastatic and\/or Locally Recurrent Nasopharyngeal Carcinoma","volume":"22","author":"Chia","year":"2014","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00162-7","article-title":"Complete Response to PD-1 Blockade Following EBV-Specific T-Cell Therapy in Metastatic Nasopharyngeal Carcinoma","volume":"5","author":"Smith","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.IMM2016-B049","article-title":"Abstract B049: Immunotherapy of EBV Associated Gastric Cancer Using EBV Specific T Cells","volume":"4","author":"Moon","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03075-w","article-title":"Mechanism of EBV Inducing Anti-Tumour Immunity and Its Therapeutic Use","volume":"590","author":"Choi","year":"2021","journal-title":"Nature"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13089","article-title":"An Open-Label, Nonrandomized, Phase Ib Feasibility Study of Cusatuzumab in Patients With Nasopharyngeal Carcinoma [Published Online Ahead of Print, 2021 Aug 18]","volume":"14","author":"De Meulenaere","year":"2021","journal-title":"Clin Transl Sci"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129641","article-title":"Tumor Infiltrating B-Cells Signal Functional Humoral Immune Responses in Breast Cancer","volume":"5","author":"Garaud","year":"2019","journal-title":"JCI Insight"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.734293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T21:28:13Z","timestamp":1673990893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.734293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":195,"alternative-id":["10.3389\/fimmu.2021.734293"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.734293","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"article-number":"734293"}}